J Korean Med Sci.  2012 Mar;27(3):317-320. 10.3346/jkms.2012.27.3.317.

Aspergillus-Associated Cerebral Aneurysm Successfully Treated by Endovascular and Surgical Intervention with Voriconazole in Lupus Nephritis Patient

Affiliations
  • 1Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. mednep@snubh.org
  • 2Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
  • 3Kidney Research Institute, Seoul National University, Seoul, Korea.

Abstract

During the last five decades, long-term therapy with immunosuppressive agents such as pulse cyclophosphamide in conjunction with high-dose corticosteroids has enhanced both patient survival and renal survival in patients with diffuse proliferative lupus nephritis. Nevertheless, severe side effects such as infectious complications remain the main cause of morbidity and mortality. Central nervous system aspergillosis is uncommon but life-threatening in lupus patients. In this single-patient case study, carotid aneurysm with sphenoidal sinusitis was suspected when severe epistaxis occurred during cyclophosphamide pulse therapy. With anti-fungal therapy, a graft stent was successfully deployed to the aneurysm and specimens of sphenoidal mucosa showed typical hyphae, indicating aspergillosis. Three months after stopping voriconazole treatment, two cerebral aneurysms that were revealed on MR images were successfully removed by aneurysmal clipping. The patient remained alive at one-year follow-up with lupus nephritis in remission. The rarity and high mortality of aspergillus-related fungal aneurysms have led to most cases being recognized postmortem. However, such aneurysms must be diagnosed early to prevent fatal complications by performing appropriate management such as surgical procedure or endovascular intervention.

Keyword

Lupus Nephritis; Neuroaspergillosis; Intracranial Aneurysm; Voriconazole; Endovascular Procedure

MeSH Terms

Antifungal Agents/therapeutic use
Female
Humans
Immunosuppressive Agents/adverse effects
Intracranial Aneurysm/drug therapy/*etiology/surgery
Lupus Nephritis/*complications/drug therapy
Middle Aged
Neuroaspergillosis/drug therapy/*etiology/surgery
Pyrimidines/therapeutic use
Stents
Surgical Instruments
Triazoles/therapeutic use

Figure

  • Fig. 1 (A) Aneurysm involving the cavernous segment of the left carotid artery in transfemoral cerebral angiography (black arrow). (B) Cerebral angiography after deploying graft stent in cavernous internal carotid artery for parent vessel reconstruction.

  • Fig. 2 (A) Aneurysm at right middle cerebral artery bifurcation (black arrow) and tiny aneurysm at the origin of right anterior choroidal artery (white arrow). (B) Cerebral angiography after aneurismal clipping.


Reference

1. Contreras G, Pardo V, Leclercq B, Lenz O, Tozman E, O'Nan P, Roth D. Sequential therapies for proliferative lupus nephritis. N Engl J Med. 2004. 350:971–980.
2. Gourley MF, Austin HA 3rd, Scott D, Yarboro CH, Vaughan EM, Muir J, Boumpas DT, Klippel JH, Balow JE, Steinberg AD. Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial. Ann Intern Med. 1996. 125:549–557.
3. Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, Garrido Ed Ede R, Danieli MG, Abramovicz D, Blackmans D, Mathieu A, Direskeneli H, Galeazzi M, Gül A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum. 2002. 46:2121–2131.
4. Illei GG, Austin HA, Crane M, Collins L, Gourley MF, Yarboro CH, Vaughan EM, Kuroiwa T, Danning CL, Steinberg AD, Klippel JH, Balow JE, Boumpas DT. Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis. Ann Intern Med. 2001. 135:248–257.
5. Bouza E, Moya JG, Muñoz P. Infections in systemic lupus erythematosus and rheumatoid arthritis. Infect Dis Clin North Am. 2001. 15:335–361.
6. Navarra SV, Leynes MS. Infections in systemic lupus erythematosus. Lupus. 2010. 19:1419–1424.
7. Weng CT, Lee NY, Liu MF, Weng MY, Wu AB, Chang TW, Lin TS, Wang JY, Chang HY, Wang CR. A retrospective study of catastrophic invasive fungal infections in patients with systemic lupus erythematosus from southern Taiwan. Lupus. 2010. 19:1204–1209.
8. Chen HS, Tsai WP, Leu HS, Ho HH, Liou LB. Invasive fungal infection in systemic lupus erythematosus: an analysis of 15 cases and a literature review. Rheumatology (Oxford). 2007. 46:539–544.
9. Gonzalez-Crespo MR, Gomez-Reino JJ. Invasive aspergillosis in systemic lupus erythematosus. Semin Arthritis Rheum. 1995. 24:304–314.
10. Uppin MS, Challa S, Uppin SG, Alladi S, Yarlagadda JR. Cerebral Aspergillus arteritis with bland infarcts: a report of two patients with poor outcome. Neurol India. 2007. 55:298–300.
11. Lammens M, Robberecht W, Waer M, Carton H, Dom R. Purulent meningitis due to aspergillosis in a patient with systemic lupus erythematosus. Clin Neurol Neurosurg. 1992. 94:39–43.
12. Sugawara A, Ebina K, Hirano T, Ohi H, Yoshimura S, Akabane M. Multiple aspergillus brain abscess complicated with systemic lupus erythematosus: case report. Neurol Med Chir (Tokyo). 1991. 31:986–990.
13. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 7-1988. A 27-year-old man with acute myelomonocytic leukemia in remission and repeated intracranial hemorrhages. N Engl J Med. 1988. 318:427–440.
14. Hope WW, Walsh TJ, Denning DW. The invasive and saprophytic syndromes due to Aspergillus spp. Med Mycol. 2005. 43:S207–S238.
15. Hot A, Mazighi M, Lecuit M, Poirée S, Viard JP, Loulergue P, Suarez F, Dupont B, Merland JJ, Lortholary O. Fungal internal carotid artery aneurysms: successful embolization of an Aspergillus-associated case and review. Clin Infect Dis. 2007. 45:e156–e161.
16. Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH, Hodges MR, Schlamm HT, Troke PF, de Pauw B. Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002. 347:408–415.
17. Schwartz S, Reisman A, Troke PF. The efficacy of voriconazole in the treatment of 192 fungal central nervous system infections: a retrospective analysis. Infection. 2011. 39:201–210.
18. Lueg EA, Awerbuck D, Forte V. Ligation of the common carotid artery for the management of a mycotic pseudoaneurysm of an extracranial internal carotid artery. A case report and review of the literature. Int J Pediatr Otorhinolaryngol. 1995. 33:67–74.
19. Reisner A, Marshall GS, Bryant K, Postel GC, Eberly SM. Endovascular occlusion of a carotid pseudoaneurysm complicating deep neck space infection in a child. Case report. J Neurosurg. 1999. 91:510–514.
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr